Literature DB >> 23323784

Drug delivery to the ear.

E Hoskison1, M Daniel, S Al-Zahid, K M Shakesheff, R Bayston, J P Birchall.   

Abstract

Drug delivery to the ear is used to treat conditions of the middle and inner ear such as acute and chronic otitis media, Ménière's disease, sensorineural hearing loss and tinnitus. Drugs used include antibiotics, antifungals, steroids, local anesthetics and neuroprotective agents. A literature review was conducted searching Medline (1966-2012), Embase (1988-2012), the Cochrane Library and Ovid (1966-2012), using search terms 'drug delivery', 'middle ear', 'inner ear' and 'transtympanic'. There are numerous methods of drug delivery to the middle ear, which can be categorized as topical, systemic (intravenous), transtympanic and via the Eustachian tube. Localized treatments to the ear have the advantages of targeted drug delivery allowing higher therapeutic doses and minimizing systemic side effects. The ideal scenario would be a carrier system that could cross the intact tympanic membrane loaded with drugs or biochemical agents for the treatment of middle and inner ear conditions.

Entities:  

Mesh:

Year:  2013        PMID: 23323784     DOI: 10.4155/tde.12.130

Source DB:  PubMed          Journal:  Ther Deliv        ISSN: 2041-5990


  3 in total

Review 1.  Intratympanic corticosteroids for sudden sensorineural hearing loss.

Authors:  Stefan K Plontke; Christoph Meisner; Sumit Agrawal; Per Cayé-Thomasen; Kevin Galbraith; Anthony A Mikulec; Lorne Parnes; Yaamini Premakumar; Julia Reiber; Anne Gm Schilder; Arne Liebau
Journal:  Cochrane Database Syst Rev       Date:  2022-07-22

Review 2.  Update on otitis media - prevention and treatment.

Authors:  Ali Qureishi; Yan Lee; Katherine Belfield; John P Birchall; Matija Daniel
Journal:  Infect Drug Resist       Date:  2014-01-10       Impact factor: 4.003

3.  Efficacy and safety of fluocinolone acetonide 0.025% otic solution in patients with otic eczema: a randomized, double-blind, placebo-controlled clinical trial.

Authors:  Victoria Montoro; Carlos Asensio; Ángel Martínez; Juan Lorente; Francisco J Rodríguez; José Montojo; Javier Gavilanes; Pedro Sarría; Cristóbal Langdon; Eduard Prades
Journal:  J Int Med Res       Date:  2018-08-24       Impact factor: 1.671

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.